Abstract
Current pathogenic concepts of inflammatory demyelinating disorders such as multiple sclerosis (MS) are based on the hypothesis that a T cell-mediated autoimmune response is involved in the disease process. One of the primary goals in the in the development of immunotherapies for autoimmune diseases has been to achieve inactivation of disease-inducing lymphocytes either by direct inhibition or suppression through regulatory cells and/or cytokines. The CD26 antigen is identical with the cell surface ectopeptidase dipeptidyl peptidase IV (DP IV, EC 3.4.14.5) which is involved in regulating T cell activation and growth. Activated T cells, including those specific for myelin antigens, express high levels of CD26/DP IV. In vitro, reversible DP IV inhibitors suppress T cell proliferation and pro-inflammatory cytokine production in response to myelin antigens. Further studies will evaluate the role of DP IV inhibition in T cell-mediated inflammatory disease of the central nervous system.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brocke, S., et al., 1996, Isolation and characterization of autoreactive T cells in experimental autoimmune encephalomyelitis of the mouse. Methods 9: 458–462.
De Meester, I., et al., 1999, CD26, let it cut or cut it down. Immunol. Today 20: 367–375.
Fujinami, R.S., and Oldstone, M.B., 1985, Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230: 1043–1045.
Hemmer, B., et al., 1997, Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 185: 1651–1659.
Kä, T., et al., 1999, Dipeptidyl peptidase IV: A cell surface peptidase involved in regulating T cell growth. (Review). Int. J. Mol. Med. 4: 3–15.
Karpus, W. J., 1999, Chemokine regulation of inflammatory-mediated nervous system diseases. J. Neurovirol. 5: 1–2.
Karpus, W.J., and Ransohoff, R.M., 1998, Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J. Immunol. 161: 2667–2671.
Mason, D., 1998, A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19: 395–404.
Morimoto, C., and Schlossman, S.F., 1998, The structure and function of CD26 in the T-cell immune response. Immunol. Rev. 161: 55–70.
O’Garra, A., L. Steinman, and Gijbels, K., 1997, CD4+ T-cell subsets in autoimmunity. Curr. Opin. Immunol. 9: 872–883.
Reinhold, D., et al., (l993, Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells and IL-2 and IL-6 production. Immunobiol. 188: 403–414.
Reinhold, D., et al., 1997a, Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-β1 in PWM-stimulated PBMC and T cells. Immunology 91: 354–360.
Reinhold, D., et al., 1997b, Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) induces secretion of transforming growth factor-βl (TGF-βl) in stimulated mouse splenocytes and thymocytes. Immunol. Lett. 58: 29–35.
Schö, E., et al., 1984, Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylprolin in T-lymphocytes. Biochem. J. 223: 255–258.
Schö, E., et al., 1987, The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur. J. Immunol. 17: 1821–1826.
Von Bonin, A., et al., 1998, Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway. Immunol. Rev. 161: 43–53.
Wucherpfennig, K.W., and Strominger, J.L., 1995, Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80: 695–705.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Steinbrecher, A. et al. (2002). Dipeptidyl Peptidase IV in Inflammatory CNS Disease. In: Langner, J., Ansorge, S. (eds) Cellular Peptidases in Immune Functions and Diseases 2. Advances in Experimental Medicine and Biology, vol 477. Springer, Boston, MA. https://doi.org/10.1007/0-306-46826-3_16
Download citation
DOI: https://doi.org/10.1007/0-306-46826-3_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46383-9
Online ISBN: 978-0-306-46826-1
eBook Packages: Springer Book Archive